-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 JwBXW4RQEiHAQ4nyWVX/IjQKltDIZOBQwa97bqSMWmRi3Rw5tq5EC73ROsVNQXVW
 ueE4iBvQNqOV3IKGP5VThA==

<SEC-DOCUMENT>0001193125-10-028696.txt : 20100211
<SEC-HEADER>0001193125-10-028696.hdr.sgml : 20100211
<ACCEPTANCE-DATETIME>20100211160038
ACCESSION NUMBER:		0001193125-10-028696
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20100211
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20100211
DATE AS OF CHANGE:		20100211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARROWHEAD RESEARCH CORP
		CENTRAL INDEX KEY:			0000879407
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				460408024
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21898
		FILM NUMBER:		10591812

	BUSINESS ADDRESS:	
		STREET 1:		201 SOUTH LAKE AVENUE
		STREET 2:		SUITE 703
		CITY:			PASADENA
		STATE:			CA
		ZIP:			91101
		BUSINESS PHONE:		626-304-3400

	MAIL ADDRESS:	
		STREET 1:		201 SOUTH LAKE AVENUE
		STREET 2:		SUITE 703
		CITY:			PASADENA
		STATE:			CA
		ZIP:			91101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERACTIVE GROUP INC
		DATE OF NAME CHANGE:	20020509

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERACTIVE INC
		DATE OF NAME CHANGE:	19940224
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P
STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>WASHINGTON, D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P
STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 8-K </B>
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P
STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman"
SIZE="3"><B>PURSUANT TO SECTION 13 OR 15(D) OF THE </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>SECURITIES EXCHANGE ACT OF 1934 </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Date of Report (Date of earliest event reported): February&nbsp;11, 2010 </B></FONT></P> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px"
ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>Arrowhead Research Corporation </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Exact name of
registrant as specified in its charter) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P
STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>0-21898
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Commission File Number) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>46-0408024</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(State or other jurisdiction</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"
ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of incorporation)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(IRS Employer</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Identification No.)</B></FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>201 South Lake Avenue, Suite 703,
Pasadena, CA 91101 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive offices) (Zip Code) </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Registrant&#146;s telephone number, including area code (626)&nbsp;304-3400 </B></FONT></P> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P
STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b) </FONT></TD></TR></TABLE> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4 (c)&nbsp;under the Exchange Act (17 CFR 240.13e-4(c) </FONT></TD></TR></TABLE> <P
STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P
STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;2.02.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Results of Operations and Financial Condition. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On February&nbsp;11, 2010, Arrowhead Research Corporation announced and commented on its financial results for the quarter ended December&nbsp;31, 2009. A copy of the press release is attached hereto as
Exhibit&nbsp;99.1. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form
8-K, including Exhibit&nbsp;99.1, shall not be deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;<U>Exchange Act</U>&#148;), or otherwise subject to the liability of that section,
nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific reference in such filing to
this Current Report on Form 8-K. </I> </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Item&nbsp;9.01.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financial Statements and Exhibits. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B><I>(d)&nbsp;Exhibits </I></B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:39pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exhibit&nbsp;No.</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Description</B></FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top" NOWRAP ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">99.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Press Release, dated February&nbsp;11, 2010.</FONT></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date: February&nbsp;11, 2010 </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0">

<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">ARROWHEAD RESEARCH CORPORATION</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/&nbsp;&nbsp;&nbsp;&nbsp;K<SMALL>ENNETH</SMALL> A. M<SMALL>YSZKOWSKI&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</SMALL>
</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Kenneth A. Myszkowski</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"
ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Chief Financial Officer</B></FONT></P></TD></TR></TABLE></DIV>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE, DATED FEBRUARY 11, 2010
<TEXT>
<HTML><HEAD>
<TITLE>Press Release, dated February 11, 2010</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P>
 <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g94561g23s78.jpg" ALT="LOGO"> </P>
 <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PRESS RELEASE</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman"
SIZE="2">February&nbsp;11, 2010</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Investor&nbsp;Relations&nbsp;Contact:</B></FONT><BR> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman"
SIZE="2">Brandi Floberg</FONT></P> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Piacente Group, Inc.</FONT></P> <P STYLE="margin-bottom:0px; margin-top:0px" ALIGN="right"><FONT
STYLE="font-family:Times New Roman" SIZE="2">212-481-2050</FONT></P> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">ir@arrowres.com</FONT></P></TD></TR></TABLE> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARROWHEAD REPORTS FISCAL 2010 FIRST QUARTER FINANCIAL RESULTS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>PASADENA, Calif. &#150; Arrowhead Research Corporation (NASDAQ: ARWR) </B>today announced financial results for its fiscal 2010 first quarter ended December&nbsp;31, 2009. </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;During the first quarter, we made steady progress in advancing our portfolio companies, and at Arrowhead where we further improved our cost structure
and strengthened our balance sheet with the completion of our financing in December,&#148; said Christopher Anzalone, Arrowhead&#146;s CEO. &#147;In the short time since our last earnings release, Unidym in particular has made excellent business
development progress by completing several partnering and licensing agreements with industry leaders. Our nanobiotech portfolio companies are continuing clinical and technical development and we are exploring exciting new opportunities for future
investment in the life sciences industry. Additionally, we completed the sale of essentially all of Tego Biosciences&#146; assets, bringing in a modest upfront payment while retaining future upside potential. </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#147;To support progress with our businesses, we have enhanced our leadership team through several key appointments including a new CFO and the addition of
distinguished experts to both Unidym and Calando&#146;s boards. These types of business, technical and organizational developments are indicators of our company&#146;s evolution as we look to add value through the advancement of our subsidiaries. We
believe that fiscal 2010 will prove to be an exciting year for Arrowhead and our shareholders,&#148; Dr.&nbsp;Anzalone concluded. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>FIRST QUARTER FISCAL 2010 AND RECENT COMPANY HIGHLIGHTS: </B></FONT></P> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#149;</B></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Business highlights: </B></FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unidym extended its partnership with Samsung Electronics for flexible displays into a third year and entered into a new JDA with another major LCD
manufacturer for glass based LCDs. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unidym entered into a joint venture to market and co-develop its films and electronic ink products into the Korean touch panel and display industries.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unidym entered into license agreements with four companies for applications outside its core electronics focus. </FONT></P></TD></TR></TABLE> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company completed the sale of Tego&#146;s assets to Luna Innovations, Inc. The purchase price included up-front payments of $430,000 with
additional milestone payments in the future. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#149;</B></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Financial highlights: </B></FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Decreased quarterly operating expenses by 75% versus the prior year&#146;s quarter to $2.3 million. </FONT></P></TD></TR></TABLE> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Decreased cash used in operating activities from $7.7 million in the prior year quarter to $1.6 million in the current quarter.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">On December&nbsp;11, 2009, completed a private placement for gross proceeds of $3.2 million. </FONT></P></TD></TR></TABLE> <P
STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SELECTED FISCAL 2010 FIRST QUARTER FINANCIAL RESULTS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">For the quarter ended December&nbsp;31, 2009, Arrowhead reported revenue of $148,000, compared with $702,000 in the quarter ended December&nbsp;31, 2008. The prior period revenue included $535,000 in
proceeds from license fees and grants, which were not repeated in the current period. The sale of carbon nanotubes by Unidym comprised comparable revenue in both periods. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Total operating expenses for the quarter ended December&nbsp;31, 2009 were $2.3 million, a decrease of $7.0 million from $9.3 million during the quarter ended December&nbsp;31, 2008. The significant
reduction in operating expenses was a result of measures undertaken by management during 2009 to streamline its businesses and better align its cost structure with its capital resources. </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Net loss for the quarter ended December&nbsp;31, 2009 was $1.5 million, or $0.03 per share based on
58.6&nbsp;million weighted average shares outstanding. This compares with a net loss of $8.0 million, or $0.19 per share based on 42.9&nbsp;million weighted average shares outstanding, for the quarter ended December&nbsp;31, 2008. </FONT></P> <P
STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U>Conference Call </U></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company will
conduct a financial announcement conference call on, Thursday, February&nbsp;11, 2010, at 4:30 p.m. Eastern time/1:30 p.m. Pacific time to discuss the Company&#146;s results. To participate in the conference call, please dial 877-941-4774 toll free
from the US or Canada, or 480-629-9760 from outside the US. Investors may also access a live audio webcast of this conference call on the Company&#146;s website at www.arrowheadresearch.com. </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">A replay of the webcast will be available approximately two hours after the conclusion of the call. The webcast replay will remain available for 90 days. An
audio replay will also be available approximately two hours after the conclusion of the call and will be made available until Thursday February&nbsp;18, 2010. The audio replay can be accessed by dialing 800-406-7325 toll free from the US or Canada,
or 303-590-3030 internationally, and entering access ID number 4220149#. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>About Arrowhead Research Corporation </I></B></FONT></P> <P
STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arrowhead Research Corporation (www.arrowheadresearch.com) (NASDAQ: ARWR) is a nanotechnology company commercializing new technologies in the areas of life
sciences and electronics. Arrowhead is seeking to build value for shareholders through the progress of its subsidiaries and investments. Currently, Arrowhead is focused primarily on its two majority owned subsidiaries; Unidym, a leader in carbon
nanotube technology for electronic applications, and Calando, at the forefront of clinical application of RNAi delivery technology. Arrowhead also has minority investments in two privately held nanobiotech companies. </FONT></P> <P
STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: </I></B></FONT></P> <P
STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>This news release contains forward-looking statements within the meaning of the &#147;safe harbor&#148; provisions of the Private Securities Litigation
Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various
factors and uncertainties, including the future success of our scientific studies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and
competitive developments, the financial resources available to us, and general economic conditions. For example, there can be no assurance that Arrowhead or its subsidiaries will be able to sustain operations for expected periods, that we will be
able to achieve or sustain targeted levels of expense reductions or that any of these entities will be successful in obtaining additional funding needed to sustain operations. Arrowhead Research Corporation&#146;s most recent Annual Report on Form
10-K and subsequent Quarterly Reports on Form 10-Q discuss some of the important risk factors that may affect our business, results of operations and financial condition. We disclaim any intent to revise or update publicly any forward-looking
statements for any reason. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I># # # </I></FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g94561g23s78.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g94561g23s78.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````/```_^X`#D%D
M;V)E`&3``````?_;`(0`!@0$!`4$!@4%!@D&!08)"P@&!@@+#`H*"PH*#!`,
M#`P,#`P0#`X/$`\.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-#`T8$!`8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\``$0@`50"L`P$1``(1`0,1`?_$`*,``0`"`P$!`0``````
M```````$!0,&!P@!`@$!``,!`0$```````````````$"`P0%!A```0,"!0(#
M!@()`P4``````@$#!``%$1(3!@<A,4$B%%%A,B,5%D(S<8&14F*3TR07H<%6
M-%65)P@1``("`0(%`@0#!`L````````!$0(#(00Q05$2$V$4<8$B,I&A8L%"
M4@7PL='A\7*2HB,D%?_:``P#`0`"$0,1`#\`]4T`H!0"@%`*`4`H!0"@*=[=
MMB9E>G*2"JBX&XAMY!5.BH6)(O3]%5[T<MMYC3B2V;<;<;%QLD,#1"$A7%%1
M>RHM6.E.3]4)%`*`4`H!0"@%`*`4`H!0"@%`*`4`H!0"@-8WSNN%98*1RE,L
M39:*C0OFZVF3L9(3(.&*ICTZ56UH.+>[CQUA-=SZS^PYE]QQ?^Z,?^1NO]*L
MNY'A>1]5_JO_`&&\<?;Q@RR6SN36'I'4H@MO27S)$Q4T(Y+8+T\$QK2EI/5_
ME^YGZ&U/+B_ZT;Y5SU10"@%`*`4`H!0"@%`*`4`H!0"@%`*`4!@GSHD"&],E
MN(U&8%3=<7L@I4-D-I*6<7O&Z7I]R?EM;P&,PX2JS&&*\HMA^$>H+^OWU@[/
MJ>5D;LY5_P`C:[1M7<<S;+LE-PN.S)61V!)1K((M)U5%;(4)<Z?[5=5<<3>F
MWNZ_=J:8-\GQWT7[V076BZB41WHHKU14R?J6LY?4YDK)_?\`D=DV]?H%[MC<
MV$^+X_`Z0(0HC@IYDRE@2>[&NA.3U<=U92BSJ2XH!0"@%`*`4`H!0"@%`*`4
M`H!0"@%`<HY1Y`9:G%8&83-P89P*:CZ.*&KW$$TR#X?'WU2_0Y\M^14<?Q(>
MY[NK3FW8#,",F>4\(OHO7X`',YAB2_Z56M?0ICHK/@=M$1$4$401%,!1.B(B
M5J=9ROE*UQ+,Z%X8L4*9'EFJ3'71=4Q>7JBKD,4P/]'>L[5.;+1+6"CV+R/'
MMEV;C':XUOMTPT"2Y'%Y%$NP&N<S3!,>O3M2NA&.Z3.XHJ*F*=46M#J%`*`4
M`H!0"@%`*`4`H!0"@%`*`4!JG)6]6MI[:=F`F>X2,6;>UACBZJ?$J)^$$ZK5
MJ5EF6;)V5D\[Q=^\AS);46/<IKTF08MM`BKB1FN")V]M;O$D><LUFST[M:U3
M;98XL6?*.;/$$*7)<7%2<+J6'\(]DKG9ZE$TM2VJ"QAF1DDQ7HZF3>J"AJ`N
M!"JIAF%?:G=*$-2>8MT[CY&VY?I=GF7683D<OENHJY7&RZ@8]/Q)717&FI/,
MR9+U<,ZQPMR$_N*V.VNZ&17B!YM5Q%0GF"7H>*]R%>A?JK/)3M.O;YNY0^)T
MNLSI%`*`4`H!0"@%`*`4`H!0"@%`%H#RGS)RAO>-R'=+?$N,BVQ+>0L1X[)*
M"**"A:B^U3S8X^RO3V^"KHF>'N\^19&DX-*3E7D%%Q3<,U%3LJ.K6_MZ=#E]
MQEZLV;C7DK?5PW_8(,R_39$21-:;>8<=(@,57J))[*RS8*JCA'1ML^1Y$F^9
MZ[KRCWCS7_\`06^]W6/?PPK3>)4&*L)ES08<4`S$1HI8)XKA7H[7%6U9:/'W
MV6];PG"@YD7*O()+B6X9I+[5=5:Z?;TZ'%[C+U9.L'+O(,6]P'TO$J9E?;18
MCAJ8.H1(BMJ/CFQPJM]O2.!?'N,JLM3VD*JJ(JI@J^%>.?1'V@%`*`4`H!0"
M@%`*`4`H!0"@%`:UN;C;8^YY02[[:&9DIL<@R%S`YE3L*DVHJJ)[ZTIEM7@S
M*^&MN**7_`W$W_'FOYK_`/4J_N<G4I[7'T)5JX9XTM5RC7*WV1MB;$<1V.\C
MCRJ)CV7!35*BVXNU#9-=O1.4C=:Q-S5=R\7[#W-<OJ5\M039J-BTCQ&Z*Y!5
M5%,`(4_$M:4S6JH3,KX*6<M%5_@;B7_CS7\U_P#J5?W.3J4]KCZ$^R<1<;V2
MX-7&VV)AF:RN9EXE-Q0+]X=0B1%]]5MGNU#9:NWI5RD;A61L*`4`H!0"@%`*
M`@WV]0;)9IEWGGIPX+)OO%_""8X)[U[)4UJ[.$5M954LT?B[E*X[JGS+7?;8
M-GNK;#-PA1D(BUH4A,0<\WBF*8_IK?-A5=4Y1CAS.SAJ"VMO+?']QNK=JB73
M/.==<8:`F7P$W6<5,!,P$%),.V-4>"Z4P66>C<2?;'RWQ]>[@U`MUV%R2\+A
MLBXT\R)HRBJYE-T`!<B(JKUI;!=*6A7/1N$S';N8>.KC<VK;$O`&^^XK,9PF
MW08=<1<,C3Q"C9KC["ZU+P72F`MQ1N))3O*&QFMN.[C=N8A9V)"PW9!-NHHR
M!+*K:MY=3,B_PU'AM,1J3YJQ/(Q;JY(L-FMN>/("3<Y5O?N5JB8&HOM,-*[F
M4A14`53Q7"E,+;])(R9E5?(KMC<R;1W(Q:HKLT(M_N#(F5O4'@'5RXFVTXX`
MB>'N6K9-O:L]"N+<5M'4L7^6=@LW,[:ESUY;;J1W$CL/O@+JKER$XTV8(J+W
M\W2J^&T3!9YZ3$F.X\O;`MLR1$GW!R.[%<)F01Q92-@8KE7%W2R88^..%%@L
M^"#ST3ADR^<E;'L:Q1N-V:!R:T+\1II#?<<:),1<$&1,LJ^"X5%<-K<$3;-6
MO%D/BS?C^]K#,NKL=N.+$]^(R+:E@33650-<^"H1(75*G-C['!&'+WJ35(?*
M/(-VO%^B6:V69(MDG.P5<G3'&'#TU7`LN54ZI6SPT24MZF2S7;<):%SM'F2Q
MW/9Q[AOZMV5(\QRW.AG5X''V\%_MU$<SF;'HB)6=]NU:%J7IN$ZR]"U3EK8/
MTMZZ.7(F8;#H,&;T>0T1.NHJ@#8&V)FJH*_"BU7PVF(+>>D3)(M/)6S;J$QR
M+.(&H#*R)CLAA^,#;2+@I*;X-C^RHMBLN1-<U68+9RML:YN.A`G./Z++DDC&
M+*0%:9',9":MH)=.R(O7PJ;8;+B17/5\#Y;.6M@W*Y1K;'N:A-F%DBM2&)$?
M4/\`=`GFP%2]V-'@LE,"N>C<2&^6M@'>_HB73"X^J6!IDR^(>J1<NEJJ&GFQ
M_BIX+Q,:#STF)#O+?'S=W6TC=4>G"\D8P89?>`72+)D)QL"!%Q[^;I3P7B8'
MGI,2:]8^=]LE+N\/<K[=ID6^YOP&%0'S;)IHLH...H"M@I+CBBK6EMM;1K70
MSKNJRU;2&=-UV=#7U!T<N?5Q3+EPQS8^S"N8Z9-'Y5V;?]Y1+98(KP1K"]*%
MV_O9U%\F&NHMM#E)%52Z]?8E;X<BI+Y\C'/C=X7+F:_/X>O=IW+8MS;:O$JX
MW&W.HQ,:O$G.)0"14-IL@;Z=^B+T_95UN$ZNMEQZ&;V[33J_Q+GCKCAVRV&1
M&OL:+(N`72;<+:Z/S=%)/0"$B$5$\.^%4RY9>G0OBQ0M>)$V?Q*L?C8-N7]N
M/]7;;GLQY[/S2CC.(\2:,A$DQ$DS5.3--Y7#0C'@BD/CJ4*\9<BW+;-CV1<V
M[7$LEED,NG>(SCAR'6XQ*H(VRH"@&6/F)2K3S45G93+,_#=I5<0B7.X6N$SD
M"0Z^XP>PIDLKO)MJDNHL\V%97RY<N7,N?O4+<)4_5P)>V;O^DA[7X:W;"M^X
M!O,N/+FK:'+#MHD,E%N(N=45Q5%,I*I"BX8]*F^XJVHZRR*;>R3GI"+ESC7<
M10>-&4*/J;3=;.ZKJ%U$6A!=%<OFZCXX53S*;?J+^%Q7T-?V_P`.[UVW+*+$
M<]=;?6K);?;N\R`NF1H6#D9MLVR-$3KYO-6E]Q6R]?@9UV]JOT^)\W#Q;RC<
MAO\`&ERANHW)U]8,MR[2XS33#GY;90@:)HD#V8X+2F>BCE\B+X+N?7U+6U<;
M[ZVU>+3N"RC;I\YNR1;/<8,QUQH0*.(HKD=X`/HN7Q&J/+6R:<\9-*XKU::C
MA!LW$.T;[M?;T^)>D829,N4F=EC&3C8B_E5$S$(+T5%\*SSW5GIT-,%'5.>I
MK%LX&MD][>#FZ(<9Y^]3WW[3.:53?89=15%<50<I(77#K6MMTUV]O(SKMDYG
MF0)7#N\YVRMO6QYR#'NNU9AN1/2NN1VI<<L$0B<:!#9>\OQ(*^VK+<55F]8L
M4>WLZI<T3'^-]T3=NNP[E:6ITH9C,F(,F^S75:5L"176I"LYVR151,J)@O?P
MJOEJK2GRZ%O#9UAK\R.WQ)OZ[6[<5MNUS6#:[I"!B'`*=(NB#*;=%U'B<?!L
MA%<F513VU+ST332U7R(6"[33>GQDSV#CKDF!"D0PD>@E?3W(L2Y#=YDML'LB
M"!C$=:$`3ITP7$/"HOEHW\^A-,-U_B53?$O(DFX;;>N"-F=HG1Y<Z8_>)<W5
M1I4U%;8=:$&R+OT7W5?ST2<<_0I[>[:GEZF\[)XY.`_N,MP1XTMNX7QV[VQ/
MS5:0D1&W/,*9'!Z]OVUADRS$=(-\>&)GFY*S8VT^2-C,G8K?&M5TL93#D!.=
M?>CRD:>/$\[:-."1BG;S5;+DI?5S)7'2]--((SO%FY3X^WQ8$*,L[<-SD3;<
MJN%IHTZXV8ZA9,1+`%[(M3YUWU?1$+"^VRZLZ)])E?9_TCR^K^G^DQQ\FIH:
M??#MF]U<\_5)T=OTQZ%Q52XH!0"@%`5>X+R]:V(Q,1_4ORY+<5EM3TQS.8X*
M18%T3+[*K9P<^YSO&E"EMI?B5S^Y[NP#+3MK!)\B9Z-EE)`JVORE=SJX@XIT
M%4P4:CN?0PMN\B23K]3M''TDC3-\2H+$OUEO!J5$DQXQAKXM?W0YA-7$#%$'
MQ\M'>#.^_M1/NK#K9+CU,/\`D5%M:SABM&/K0A`X+RDP>=O/J"[IXJ@X95\O
M>H\FA3_T_H[H_>[>.GQF#-%WO-EC';C6T3E29+T9I%>46B1EI'2<%PFT54P7
M#X>].^2]-_:T)5U;:XZ:*>A\F;[?AQ3.3!;:DM3TM[H$_P#*%59UD<U$#'#+
MT^&GD*W_`)BZUUK#5^WCIPGB!Y!96Q'<O3"3Q25B0V0>33D$@H:FVZ8@F7+C
MUP\*>322?_37C[X_>A:\?@S/*W?+5JUR;;";F0KN0-Q7B?TUU#`CRD.0L,N1
M47KWJ7?A!>^]M%72O=6_#4_<W=S\8Y,=(2.2V'X<46]5$$G9@HJ>;+T057V=
M:.Y;)O765VZIU7'G8PR]YSX(7$)MKPE0&XSHL,/(YJC)=5H4$E$,"14H[^AG
M??VIW=U=:QHGQEP6%FW7!NUP*)$150(Z/.J7E-L]16R9<;7J)CEZXU*O+-\&
M\KEOVUZ3\/1EW5CL%`*`4`H!0"@%`*`4`H"HW-]O_3P^N8>EU0TOCS:W7)DT
M_/F[]JK:(U.;=>+M_P"3A/KQ^12?^NOI2]O2^K3'_J-;U>G_`#LVG_I5?I@Y
M/^KV>G=^J>Z/QX$BV?8FE_9Y</6,8ZFMJ>KP^1FU?/CA\./2I7::8O;Q]/\`
M$NOW<N))C_9^8=#3R_4/E9<^GZ[*6.G^#-AFQR],>_6B@M3P<H^__<9=T?;&
M2+]<[YR]'EU=3/E\V31\_P`/>IM',MN_#IY/EQ_81+7]D:,?T67+Z[Y6?5S^
MMTE^+4\^;3_>\*K7M,\7MX7;_%Z_='KZ'R-]@ZK63T^7,_Z;5QT,<PZ^CJ?+
M^+#'+^JI^DBOM97V\XZ>L3I^!(B_9^C$]+I:'KC]%DS:?K,#SZ>'3][MY:*"
M]/!"[8CNT_S>G](/S>/LW+</J63'5C^N_,S:V">GPR>;-A\.6EHYC/X/J[^J
MGCQY$.#_`(_T)FAAEQC^LUM?/^9_;XZOGPU.V'3&H7:9X_;0X])F>NG'U+F+
M]N_<$STNC];T@]=I_F:>*Z>IAT_1CUJRB?4Z:>+ROMCR1K_>6M6.D4`H!0"@
$%`?_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
